Compression of morbidity in a progeroid mouse model through the attenuation of myostatin/activin signalling

Abstract

This study questions the notion that tissue growth and maintaining tissue function during ageing are incompatible mechanisms. It highlights the need for future investigations to assess the potential of therapies based on myostatin/activin blockade to compress morbidity and promote healthy ageing.